SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-029131
Filing Date
2011-05-16
Accepted
2011-05-16 08:53:12
Documents
6
Period of Report
2011-05-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-12286_18k.htm 8-K 25232
2 EX-99.1 a11-12286_1ex99d1.htm EX-99.1 96360
3 GRAPHIC g122861mmi001.jpg GRAPHIC 21888
4 GRAPHIC g122861mmi002.jpg GRAPHIC 16333
5 GRAPHIC g122861mmi003.jpg GRAPHIC 8513
6 GRAPHIC g122861mmi004.jpg GRAPHIC 1702
  Complete submission text file 0001104659-11-029131.txt   190079
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 11843612
SIC: 2834 Pharmaceutical Preparations